PULM

Pulmatrix, Inc.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001574235
$1.27 +0.79% $4.6M
Vol
Market Cap$4.6M
Cap SizeNano Cap
Inst. Holders3 funds
Inst. Value$355.4K
Inst. Activity1 buys / 0 sells
SEC Reports2
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001574235·Prev Close $1.26

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Aug 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Aug 15, 2023 HC Wainwright & Co. REITERATE Buy → Buy
May 15, 2023 HC Wainwright & Co. REITERATE Buy → Buy
Feb 7, 2023 HC Wainwright & Co. REITERATE Buy
Mar 30, 2022 HC Wainwright & Co. MAINTAIN Buy

Top Institutional Holders

FundValueMove
RENAISSANCE TECHNOLOGIES LLC$247.4K
VANGUARD GROUP INC$105.0K
BANK OF AMERICA CORP$3.0KDOUBLED
3 institutional holders with $355.4K total value (159,367 shares) as of 2025-Q4. Top holders: RENAISSANCE, VANGUARD, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1RENAISSANCE TECHNOLOGIES LLC110,920$247.4K69.6%
2VANGUARD GROUP INC47,082$105.0K29.5%
3BANK OF AMERICA CORP /DE/1,365$3.0K0.9%DOUBLED +4036.4%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
BANK OF AMERICA CORP /DE/DOUBLED331,365+4036.4%$3.0K2025-Q4
UBS Group AGNEAR_EXIT5,463129-97.6%$627.002025-Q3
UBS Group AGDOUBLED1,1555,463+373.0%$37.7K2025-Q2
UBS Group AGNEAR_EXIT4,9201,155-76.5%$7.7K2025-Q1
UBS Group AGDOUBLED3924,920+1155.1%$34.3K2024-Q4
CITADEL ADVISORS LLCEXIT10,3420-100.0%$0.002024-Q4

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Aug 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2023-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Aug 15, 2023 HC Wainwright & Co. REITERATE Buy Buy
May 15, 2023 HC Wainwright & Co. REITERATE Buy Buy
Feb 7, 2023 HC Wainwright & Co. REITERATE Buy
Mar 30, 2022 HC Wainwright & Co. MAINTAIN Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Mar 1, 20252410086%
Feb 1, 20252410086%
Jan 1, 20252410086%
Dec 1, 20242410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-13
May 8, 2026
earnings_calendar
PULM Q1 2026 Earnings Scheduled — 2026-05-08
Mar 26, 2026
earnings_calendar
PULM Q4 2025 Earnings Before Market Open — 2026-03-26